{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:25:06Z","timestamp":1789010706302,"version":"build-2803163510"},"reference-count":179,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1111\/bjd.15107","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T12:10:18Z","timestamp":1484741418000},"page":"20-43","source":"Crossref","is-referenced-by-count":152,"title":["British Association of Dermatologists\u2019 guidelines for the care of patients with actinic keratosis 2017"],"prefix":"10.1093","volume":"176","author":[{"given":"D.","family":"Berker","sequence":"first","affiliation":[{"name":"Bristol Dermatology Centre University Hospitals Bristol Bristol BS2 8HW U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"McGregor","sequence":"additional","affiliation":[{"name":"Department of Dermatology Barts Health NHS Trust London E1 1BB U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Mohd Mustapa","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists Willan House, 4 Fitzroy Square London W1T 5HQ U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Exton","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists Willan House, 4 Fitzroy Square London W1T 5HQ U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Portsmouth Dermatology Centre Portsmouth Hospitals NHS Trust Portsmouth PO3 6AD U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"McHenry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Duarte Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Swale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wakelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Y.P.","family":"Hunasehally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Natkunarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Worsnop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Brian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09026.x"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70113-G"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08268.x"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196806)21:6<1114::AID-CNCR2820210611>3.0.CO;2-G"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/372773a0"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90412-1"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019540316060"},{"key":"e_1_2_15_10_1","first-page":"171","article-title":"The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity","volume":"39","author":"Wong ST","year":"1998","journal-title":"Singapore Med J"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7062.941d"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.303"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/014107680109401209"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700110"},{"key":"e_1_2_15_15_1","first-page":"489","volume-title":"Proceedings of the Sixth National Cancer Conference, sponsored by the American Cancer Society Inc. and the National Cancer Institute, September 1968","author":"O'Beirn SFO","year":"1970"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.534"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03541.x"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13132"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.134"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb06644.x"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24284"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91658-3"},{"key":"e_1_2_15_23_1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1991.01680060103013","article-title":"Malignant potential of actinic keratoses and the controversy over treatment. A patient\u2010oriented perspective","volume":"127","author":"Dodson JM","year":"1991","journal-title":"Arch Dermatol"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010120)95:1<7::AID-IJC1001>3.0.CO;2-X"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31009"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.760"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12420"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366545"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1060"},{"key":"e_1_2_15_30_1","unstructured":"Scottish Intercollegiate Guidelines Network.Management of diabetes: a national clinical guideline. Available at:www.sign.ac.uk\/pdf\/sign116.pdf(last accessed 16 September 2016)."},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1742395310375630"},{"key":"e_1_2_15_32_1","first-page":"1462","article-title":"The paradigm shift in treating actinic keratosis: a comprehensive strategy","volume":"11","author":"Stockfleth E","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_33_1","first-page":"CD004415","article-title":"Interventions for actinic keratoses","volume":"12","author":"Gupta AK","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12036"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366530"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0502"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1997.tb00020.x"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.907"},{"key":"e_1_2_15_39_1","first-page":"25","article-title":"Treatment of actinic keratosis and photodamaged skin with 5\u2010fluorouracil 5% cream and glycolic acid peels","volume":"17","author":"Ditre CM","year":"2004","journal-title":"Cosmet Dermatol"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1992.tb03311.x"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13180"},{"key":"e_1_2_15_42_1","unstructured":"National Institute for Health and Care Excellence.Improving outcomes for people with skin tumours including melanoma. Available at:https:\/\/www.nice.org.uk\/guidance\/csg8(last accessed 16 September 2016)."},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-015-0070-9"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7599.2011.00686.x"},{"key":"e_1_2_15_45_1","unstructured":"Primary Care Dermatology Society.Actinic (solar) keratosis: primary care treatment pathway. Available at:http:\/\/www.pcds.org.uk\/ee\/images\/uploads\/general\/Actinic_%28Solar%29_Keratosis_Primary_Care_Treatment_Pathway.pdf(last accessed 16 September 2016)."},{"key":"e_1_2_15_46_1","unstructured":"Primary Care Dermatology Society.Actinic keratosis (syn. solar keratosis). Available at:http:\/\/www.pcds.org.uk\/clinical-guidance\/actinic-keratosis-syn.-solar-keratosis(last accessed 16 September 2016)."},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310143291602"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1995.01690140054008"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12168-2"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09453.x"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022137"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700098"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04292.x"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000107284.04969.5C"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(02)00456-4"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2010.01348.x"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301804"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04561.x"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2010.03999.x"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.022"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.01.047"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.4.451"},{"key":"e_1_2_15_63_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archderm.1970.04000020002002","article-title":"Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in\u00a0vivo","volume":"101","author":"Eaglstein WH","year":"1970","journal-title":"Arch Dermatol"},{"key":"e_1_2_15_64_1","first-page":"35","article-title":"Ingenol mebutate (Picato) for actinic keratosis","volume":"54","year":"2012","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_2_15_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10387.x"},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12343"},{"key":"e_1_2_15_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70114-3"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1975.tb03153.x"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70250-6"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70542-0"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06858.x"},{"key":"e_1_2_15_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07293.x"},{"key":"e_1_2_15_73_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1684\/ejd.2012.1707","article-title":"Recurrence rates and patient assessed outcomes of 0.5% 5\u2010fluorouracil in combination with salicylic acid treating actinic keratoses","volume":"22","author":"Stockfleth E","year":"2012","journal-title":"Eur J Dermatol"},{"key":"e_1_2_15_74_1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ddg.12685","article-title":"Efficacy of low\u2010dose 5\u2010fluorouracil\/salicylic acid in actinic keratoses in relation to treatment duration","volume":"13","author":"Szeimies RM","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700264"},{"key":"e_1_2_15_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.11.1498"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.4.467"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07942.x"},{"key":"e_1_2_15_79_1","first-page":"1432","article-title":"A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomes","volume":"10","author":"Foley P","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.06.018"},{"key":"e_1_2_15_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10098.x"},{"key":"e_1_2_15_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08271.x"},{"key":"e_1_2_15_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31608"},{"key":"e_1_2_15_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.020"},{"key":"e_1_2_15_85_1","first-page":"165","article-title":"Complete clearance is sustained for at least 12\u00a0months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream","volume":"10","author":"Hanke CW","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.07.004"},{"key":"e_1_2_15_87_1","first-page":"1101","article-title":"A randomized, double\u2010blinded, placebo\u2010controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses","volume":"9","author":"Jorizzo JL","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_88_1","first-page":"36","article-title":"An investigator\u2010initiated study to assess the safety and efficacy of imiquimod 3.75% cream when used after cryotherapy in the treatment of hypertrophic actinic keratoses on dorsal hands and forearms","volume":"6","author":"Goldenberg G","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_15_89_1","first-page":"156","article-title":"Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5\u2010fluorouracil cream in the treatment of actinic keratoses of the face and scalp","volume":"5","author":"Smith SR","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_90_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20132083"},{"key":"e_1_2_15_91_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01324.x"},{"key":"e_1_2_15_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04005.x"},{"key":"e_1_2_15_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.008"},{"key":"e_1_2_15_94_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111170"},{"key":"e_1_2_15_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.2766"},{"key":"e_1_2_15_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14222"},{"key":"e_1_2_15_97_1","first-page":"AB159","article-title":"Two\u2010day topical treatment with ingenol mebutate gel, 0.05% for actinic keratoses on the trunk and extremities: analysis of data pooled from two trials","volume":"66","author":"Anderson L","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_15_98_1","unstructured":"US Food and Drug Administration.Picato (ingenol mebutate) gel: drug safety communication \u2013 FDA warns of severe adverse events requires label changes. Available at:http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm459311.htm(last accessed 16 September 2016)."},{"key":"e_1_2_15_99_1","unstructured":"KuJ.Clinical review. NDA 202833. PICATO\u2122(ingenol mebutate gel PEP005 gel). Available at:http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202833Orig1s000MedR.pdf(last accessed 16 September 2016)."},{"key":"e_1_2_15_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.034"},{"key":"e_1_2_15_101_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20131803"},{"key":"e_1_2_15_102_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.451"},{"key":"e_1_2_15_103_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.542"},{"key":"e_1_2_15_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02056.x"},{"key":"e_1_2_15_105_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119649"},{"key":"e_1_2_15_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310012118"},{"key":"e_1_2_15_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08488.x"},{"key":"e_1_2_15_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07470.x"},{"key":"e_1_2_15_109_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2000.99197.x"},{"key":"e_1_2_15_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1983.tb00824.x"},{"key":"e_1_2_15_111_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.7.813"},{"key":"e_1_2_15_112_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-0963.2001.04615.x"},{"key":"e_1_2_15_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91393-9"},{"key":"e_1_2_15_114_1","first-page":"161","article-title":"Preventative effect of etretinate therapy on multiple actinic keratoses","volume":"9","author":"Watson AB","year":"1986","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_15_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01837-1"},{"key":"e_1_2_15_116_1","first-page":"S31","article-title":"European best practice guidelines for renal transplantation. Section\u00a0IV: long\u2010term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment","volume":"17","author":"EBPG Expert Group on Renal Transplantation","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_15_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.02.119"},{"key":"e_1_2_15_118_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq442"},{"key":"e_1_2_15_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.06.037"},{"key":"e_1_2_15_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10613.x"},{"key":"e_1_2_15_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09873.x"},{"key":"e_1_2_15_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12031"},{"key":"e_1_2_15_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13547"},{"key":"e_1_2_15_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12882"},{"key":"e_1_2_15_125_1","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510032887"},{"key":"e_1_2_15_126_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.1.41"},{"key":"e_1_2_15_127_1","first-page":"1049","article-title":"A randomized, blinded, bilateral intraindividual, vehicle\u2010controlled trial of the use of photodynamic therapy with 5\u2010aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities","volume":"10","author":"Taub AF","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07520.x"},{"key":"e_1_2_15_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04003.x"},{"key":"e_1_2_15_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10893.x"},{"key":"e_1_2_15_131_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11103.x"},{"key":"e_1_2_15_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1253"},{"key":"e_1_2_15_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.11.933"},{"key":"e_1_2_15_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02340.x"},{"key":"e_1_2_15_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03259.x"},{"key":"e_1_2_15_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09040.x"},{"key":"e_1_2_15_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09377.x"},{"key":"e_1_2_15_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08450.x"},{"key":"e_1_2_15_139_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09119.x"},{"key":"e_1_2_15_140_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10209.x"},{"key":"e_1_2_15_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13138"},{"key":"e_1_2_15_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13228"},{"key":"e_1_2_15_143_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12974"},{"key":"e_1_2_15_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12354"},{"key":"e_1_2_15_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04386.x"},{"key":"e_1_2_15_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12334"},{"key":"e_1_2_15_147_1","doi-asserted-by":"publisher","DOI":"10.1159\/000367958"},{"key":"e_1_2_15_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20379"},{"key":"e_1_2_15_149_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.8.976"},{"key":"e_1_2_15_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.10.023"},{"key":"e_1_2_15_151_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20012"},{"key":"e_1_2_15_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32046.x"},{"key":"e_1_2_15_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.08.035"},{"key":"e_1_2_15_154_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.687088"},{"key":"e_1_2_15_155_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1996.tb00565.x"},{"key":"e_1_2_15_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70083-2"},{"key":"e_1_2_15_157_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02783.x"},{"key":"e_1_2_15_158_1","first-page":"669","article-title":"Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery","volume":"7","author":"Berlin JM","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_159_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630902882048"},{"key":"e_1_2_15_160_1","first-page":"161","article-title":"Treatment of actinic keratoses with sequential combination of 5\u2010fluorouracil and photodynamic therapy","volume":"4","author":"Gilbert DJ","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_161_1","first-page":"35","article-title":"Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream","volume":"8","author":"Shaffelburg M","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_162_1","first-page":"255","article-title":"Efficacy of cryosurgery and 5\u2010fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis","volume":"94","author":"Hoover WD","year":"2014","journal-title":"Cutis"},{"key":"e_1_2_15_163_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00183593"},{"key":"e_1_2_15_164_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e3182467c68"},{"key":"e_1_2_15_165_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.178202"},{"key":"e_1_2_15_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12055"},{"key":"e_1_2_15_167_1","first-page":"830","article-title":"Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, U.K","volume":"95","author":"Wallingford SC","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_15_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12158"},{"key":"e_1_2_15_169_1","first-page":"539","article-title":"Real\u2010life practice study of the clinical outcome and cost\u2010effectiveness of photodynamic therapy using methyl aminolevulinate (MAL\u2010PDT) in the management of actinic keratosis and basal cell carcinoma","volume":"18","author":"Annemans L","year":"2008","journal-title":"Eur J Dermatol"},{"key":"e_1_2_15_170_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07483.x"},{"key":"e_1_2_15_171_1","first-page":"573","article-title":"Cost\u2010effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system","volume":"145","author":"Colombo GL","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_15_172_1","first-page":"23","article-title":"Pharmacoeconomic analysis of the treatment of multiple actinic keratoses","volume":"7","author":"Gold MH","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_15_173_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538670-000000000-00000"},{"key":"e_1_2_15_174_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630902887211"},{"key":"e_1_2_15_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12475"},{"key":"e_1_2_15_176_1","first-page":"184","article-title":"Cost for the treatment of actinic keratosis on the rise in Australia","volume":"3","author":"Perera E","year":"2014","journal-title":"F1000Res"},{"key":"e_1_2_15_177_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.49"},{"key":"e_1_2_15_178_1","unstructured":"ColechinE SimsA ReayCet\u00a0al.Ambulight photodynamic therapy. Available at:http:\/\/www.nice.org.uk\/guidance\/mtg6\/documents\/ambulight-photodynamic-therapy-for-the-treatment-of-nonmelanoma-skin-cancer-external-assessment-centre-report2(last accessed 16 September 2016)."},{"key":"e_1_2_15_179_1","unstructured":"Gov.uk.National tariff payment system 2014\/15. Available at:https:\/\/www.gov.uk\/government\/publications\/national-tariff-payment-system-2014-to-2015. (last accessed 16 September 2016)."},{"key":"e_1_2_15_180_1","unstructured":"Personal Social Services Research Unit.Unit costs of health and social care 2015. Available at:http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2015(last accessed 16 September 2016)."}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.15107","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:24:01Z","timestamp":1676384641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/176\/1\/20\/6747903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,18]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1111\/bjd.15107"],"URL":"https:\/\/doi.org\/10.1111\/bjd.15107","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}